Detalles de la búsqueda
1.
HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon.
Medicine (Baltimore)
; 102(22): e33897, 2023 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37266631
2.
Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings.
Microbiol Spectr
; 10(6): e0342022, 2022 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36259973
3.
Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model.
Viruses
; 15(1)2022 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36680058
4.
First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens.
Antimicrob Resist Infect Control
; 9(1): 143, 2020 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32843050
5.
Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test.
Front Microbiol
; 9: 409, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29593675
Resultados
1 -
5
de 5
1
Próxima >
>>